Intersect ENT Obtains $30,000,000 Series D Financing Round

  • Feed Type
  • Date
    2/25/2013
  • Company Name
    Intersect ENT
  • Mailing Address
    1555 Adams Drive Menlo Park, CA 94025
  • Company Description
    Intersect ENT Inc. (formerly Sinexus) is a medical device company pioneering novel therapies for Ear, Nose & Throat surgeons to utilize in providing improved treatment for their patients.
  • Website
    http://www.intersectent.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $30,000,000
  • Transaction Round
    Series D
  • Proceeds Purposes
    The financing will be used to continue the rapid commercial expansion in the United States for the company’s PROPEL and PROPEL mini sinus implants and to fund clinical studies of the company’s latest product, an office-based treatment for chronic sinusitis sufferers.
  • M&A Terms
  • Venture Investor
    Norwest Venture Partners
  • Venture Investor
    Kleiner Perkins Caufield & Byers
  • Venture Investor
    U.S. Venture Partners
  • Venture Investor
    PTV Sciences
  • Venture Investor
    Medtronic

By posting a comment, you agree to our terms and conditions.